|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | G01N 33/573 | (2006.01) |
| C07K 14/705 | (2006.01) | ||
| C12N 9/16 | (2006.01) | ||
| G01N 33/574 | (2006.01) |
| (11) | Number of the document | 2201376 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08842581.4 |
| Date of filing the European patent application | 2008-10-15 | |
| (97) | Date of publication of the European application | 2010-06-30 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-08 |
| (46) | Date of publication of the claims translation | 2012-11-26 |
| (86) | Number | PCT/FI2008/050576 |
| Date | 2008-10-15 |
| (87) | Number | WO 2009/053523 |
| Date | 2009-04-30 |
| (30) | Number | Date | Country code |
| 20070795 | 2007-10-24 | FI |
| (72) |
JALKANEN, Sirpa, FI
SALMI, Marko, FI
JALKANEN, Markku, FI
|
| (73) |
Faron Pharmaceuticals OY,
Tykistökatu 6 B, 20520 Turku,
FI
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Naujas biologinis žymuo ligų vystymosi kontrolei ir terapijos efektyvumo įvertinimui |
| A NEW BIOMARKER FOR MONITORING DEVELOPMENT OF DISEASES AND ASSESSING THE EFFICACY OF THERAPIES |
| Payment date | Validity (years) | Amount | |
| 2023-10-04 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-15 |